Navigation Links
Georgetown Lombardi Comprehensive Cancer Center Taps Ariadne for G-DOC Pathway Data and Tools
Date:2/10/2011

ROCKVILLE, Md., Feb. 10, 2011 /PRNewswire/ -- Ariadne, a leader in bioinformatics software and knowledge integration, announces today that Georgetown University signed a site license for the use of Pathway Studio® software.  In continuing its goal of adopting and applying innovative technologies, Georgetown Lombardi Comprehensive Cancer Center will employ Pathway Studio to aid researchers in their efforts to unravel cancer disease biology, disease progression, and translational medicine.  These research findings will be shared using Pathway Studio through the Georgetown Database of Cancer (G-DOC) initiative.

"Translational medicine has become increasingly important as an investigative tool to help identify biomarkers and surrogate markers involved with disease or therapeutic response.  Finding tools that can help integrate published findings with our microRNA experimental data is exciting as this advancement will enhance our ability to create disease models and hypotheses more rapidly and with greater accuracy," states Dr. Subha Madhavan, Director of Clinical Research Informatics at Georgetown Lombardi.

"Ariadne's expertise in developing biological knowledgebases for disease modeling fits nicely into Georgetown Lombardi's vision and goals.  We look to help them achieve greater understanding of cancer and to apply these discoveries to have the greatest impact in translational medicine," states Ilya Mazo, president of Ariadne.

Pathway Studio's workflow approach allows researchers to mine, integrate, analyze and visualize results individually or as an integrated workflow.  Each step can be saved, then updated or modified as new information becomes available. Separate analyses can be combined or intersected for advanced applications and discovery.  

For more information about Pathway Studio and Ariadne, visit the Ariadne website at http://www.ariadnegenomics.com, or call 240-453-6296, or email us at info@ariadnegenomics.com.

About Ariadne Ariadne (www.ariadnegenomics.com), a leader in research data products and knowledge enrichment-based software solutions, helps pharmaceutical and life science researchers tap known scientific knowledge for applications in systems biology and translational medicine. We provide a portfolio of solutions for life science, drug discovery and development applications including custom data products, knowledge extraction and visualization software, knowledge reports, and informatics staffing.

Pathway Studio, built and powered by MedScan® technology, is integrated data mining and visualization software that allows organizations and researchers to rapidly extract relevant facts and relationships from large document collections (text-mining), build focused knowledgebases (databases), while supporting the integration of OMICS experiments. The extracted knowledge is used in an interactive scaffold for defining and testing in silico-based hypotheses across a wide range of disciplines including mechanistic modelling of disease, drug action and toxicity, as well as biomarker discovery, cellular and network pathway building, protein-protein interactions and many more.

Pathway Studio is available in desktop and enterprise versions along with therapeutic-focused knowledgebases and cartridges. For more information, visit us at www.ariadnegenomics.com.

About Georgetown Lombardi Comprehensive Cancer CenterGeorgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Georgetown Lombardi is one of only 40 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.Press Contact:David DennyDirector of Marketing, AriadneEmail: marketing@ariadnegenomics.com Tel: 240-453-6296
'/>"/>

SOURCE Ariadne
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Amphotericin B - Comprehensive patent search
2. Silence Therapeutics Receives Comprehensive Protection for RNAi Structural Modification Technology in Single European Patent
3. Terrorist de-radicalization shows promise, comprehensive study finds
4. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
5. Three Nephrology TreatmentTrends Publications from BioTrends Provide a Comprehensive View of Bone and Mineral Metabolism Practice Patterns Around the Globe
6. Colorado Center for Reproductive Medicine Improves Pregnancy and Implantation Rates Using Comprehensive Chromosomal Screening of IVF Embryos
7. Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac
8. The Medical College of Wisconsin Adopts Quantros Event Manager(TM) and Claims Manager(TM) for Comprehensive Malpractice Litigation Management
9. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting
10. Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain
11. Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Tbilisi, Georgia (PRWEB) , ... October 11, 2017 , ... ... disaster, taking the lives of over 5.5 million people each year. Especially those living ... the greenovative startup Treepex - based in one of the most pollution-affected countries globally ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/9/2017)... ... 2017 , ... The award-winning American Farmer television series will feature 3 Bar ... Tuesdays at 8:30aET on RFD-TV. , With global population estimates nearing ten billion ... continue to feed a growing nation. At the same time, many of our valuable ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
Breaking Biology News(10 mins):